EIUTX
Price
$16.24
Change
-$0.11 (-0.67%)
Updated
Dec 17 closing price
RMFCX
Price
$55.64
Change
-$3.00 (-5.12%)
Updated
Dec 17 closing price
Ad is loading...

EIUTX vs RMFCX

Header iconEIUTX vs RMFCX Comparison
Open Charts EIUTX vs RMFCXBanner chart's image
Eaton Vance Dividend Builder I
Price$16.24
Change-$0.11 (-0.67%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$55.64
Change-$3.00 (-5.12%)
VolumeN/A
CapitalizationN/A
EIUTX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
EIUTX vs. RMFCX commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EIUTX is a Buy and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 104B vs. EIUTX (950M). EIUTX (1.74) and RMFCX (1.69) have matching dividends . EIUTX was incepted earlier than RMFCX: EIUTX (20 years) vs RMFCX (23 years). EIUTX is a more actively managed with annual turnover of: 49.00 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than EIUTX: RMFCX (250) vs EIUTX (1000000). RMFCX (12.63) and EIUTX (12.31) have marching annual gain over last year. RMFCX return over 5 years is better than : 40.39 vs. EIUTX (11.12).
EIUTXRMFCXEIUTX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years23 years-
Gain YTD11.47411.423100%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets950M104B1%
Annual Yield % from dividends1.741.69103%
Returns for 1 year12.3112.6397%
Returns for 3 years-12.1614.16-86%
Returns for 5 years11.1240.3928%
Returns for 10 years25.4561.8441%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc